{
    "organizations": [],
    "uuid": "b10ae4684ee5d1d65e9328a58112b13ab33d4851",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-audentes-therapeutics-q4-loss-per/brief-audentes-therapeutics-q4-loss-per-share-0-82-idUSASB0C9J9",
    "ord_in_thread": 0,
    "title": "BRIEF-Audentes Therapeutics Q4 Loss Per Share ‍$0.82",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Audentes Therapeutics Inc:\n* AUDENTES THERAPEUTICS REPORTS FOURTH QUARTER 2017 AND FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* AUDENTES THERAPEUTICS INC - ‍PLAN TO FILE IND MID-2018 AND INITIATE A PHASE 1/2 CLINICAL TRIAL OF AT982 IN Q4 OF 2018​\n* AUDENTES THERAPEUTICS INC QTRLY LOSS PER SHARE ‍$0.82 * AUDENTES THERAPEUTICS INC - ‍CURRENT CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS ARE PLANNED TO FUND OPERATIONS INTO SECOND HALF OF 2020​ Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-09T05:19:00.000+02:00",
    "crawled": "2018-03-09T14:18:01.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "audentes",
        "therapeutic",
        "inc",
        "audentes",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "audentes",
        "therapeutic",
        "inc",
        "file",
        "ind",
        "initiate",
        "phase",
        "clinical",
        "trial",
        "at982",
        "q4",
        "audentes",
        "therapeutic",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "audentes",
        "therapeutic",
        "inc",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "planned",
        "fund",
        "operation",
        "second",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}